共 50 条
Discovery of 1-arylcarbonyl-6,7-dimethoxyisoquinoline derivatives as glutamine fructose-6-phosphate amidotransferase (GFAT) inhibitors
被引:18
|作者:
Qian, Yimin
[1
]
Ahmad, Mushtaq
[1
]
Chen, Shaoqing
[1
]
Gillespie, Paul
[1
]
Le, Nam
[1
]
Mennona, Frank
[1
]
Mischke, Steven
[1
]
So, Sung-Sau
[1
]
Wang, Hong
[1
]
Burghardt, Charles
[1
]
Tannu, Shahid
[1
]
Conde-Knape, Karin
[1
]
Kochan, Jarema
[1
]
Bolin, David
[1
]
机构:
[1] Hoffmann La Roche Inc, Dept Discovery Chem & Metab Dis, Nutley, NJ 07110 USA
关键词:
Glutamine fructose-6-phosphate amidotransferase (GFAT);
Isoquinoline derivatives;
Photo cyclization;
Enzyme inhibitor;
Diabetes target;
Oral glucose tolerance test (OGTT);
INSULIN-RESISTANCE;
GLUTAMINEFRUCTOSE-6-PHOSPHATE AMIDOTRANSFERASE;
PRODUCTS;
GLUCOSE;
GENE;
D O I:
10.1016/j.bmcl.2011.09.009
中图分类号:
R914 [药物化学];
学科分类号:
100701 ;
摘要:
Through high throughput screening and subsequent hit identification and optimization, we synthesized a series of 1-arylcarbonyl-6,7-dimethoxyisoquinoline derivatives as the first reported potent and reversible GFAT inhibitors. SAR studies of this class of compounds indicated significant impact on GFAT inhibition potency by substitutions on the A-ring and C-ring. The ketone group was found to be necessary for high potency. Compound 28 (RO0509347) demonstrated potent GFAT inhibition (IC(50) = 1 mu M) with a desirable pharmacokinetic profile in rats, and showed significant efficacy in reducing the glucose excursion in an OGTT test in ob/ob mice. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6264 / 6269
页数:6
相关论文